Polydopamine/Transferrin Hybrid Nanoparticles for Targeted Cell-Killing.

Area of Science:

• Biomaterials Science
• Nanotechnology
• Cancer Biology

Background:

• Polydopamine (PDA) forms biocompatible particles that convert light to heat.
• Optimized protocols allow synthesis of PDA/protein hybrid nanoparticles, preserving protein function and enabling stimuli-induced heat generation.
• Transferrin (Tf) is a protein that binds to transferrin receptors, which are highly expressed on mouse melanoma cells.

Purpose of the Study:

• To develop and evaluate polydopamine/transferrin (PDA/Tf) hybrid nanoparticles for targeted photothermal cancer therapy.
• To investigate the efficacy of PDA/Tf nanoparticles in inducing apoptosis in melanoma cells upon UV laser irradiation.
• To validate the system in both 2D cell cultures and 3D tumor spheroid models.

Main Methods:

• Synthesis of polydopamine/transferrin (PDA/Tf) hybrid nanoparticles.
• Exposure of mouse melanoma cells (2D culture and 3D spheroids) to PDA/Tf nanoparticles.
• Irradiation of cells with a UV laser.
• Real-time monitoring of cell death rates and apoptosis induction.
• Investigation of the mechanism of apoptosis, including lysosomal membrane permeabilization.

Main Results:

• PDA/Tf nanoparticles were successfully synthesized, retaining protein function and light-to-heat conversion properties.
• UV laser irradiation of melanoma cells treated with PDA/Tf nanoparticles resulted in significantly faster apoptosis compared to control groups.
• The targeted photothermal-induced cell death was confirmed in both 2D cell cultures and 3D-printed tumor spheroid models.
• Apoptosis was mediated by lysosomal membrane permeabilization, indicating a specific cellular pathway.

Conclusions:

• Polydopamine/protein nanoparticles, specifically PDA/Tf, represent a versatile and stable system for targeted cancer therapy.
• This novel system effectively induces photothermal apoptosis in melanoma cells via UV light activation.
• The findings support the potential of PDA/Tf nanoparticles for developing advanced cancer treatment strategies.